• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER?; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER?; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number H74939419601010
Medical Device Problem Codes Material Twisted/Bent (2981); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/30/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Device evaluated by mfr: the ranger device was received for analysis.A visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.A longitudinal tear was identified in the balloon material.The tear measured approximately 24mm in length and extended from a position 21mm proximal of the distal markerband to 2mm distal of the distal markerband.The balloon material was visual examined and no twist was noted.The markerbands and tip section of the device were visually examined, and no issues were noted with the markerbands or tip of the device.A visual and tactile examination identified a shaft kink approximately 40mm proximal from the distal tip.No other issues were identified with the device.
 
Event or Problem Description
Reportable based on device analysis completed on 05jan2026.It was reported balloon twisting occurred.The 75% stenosed target lesion was located in the moderately calcified superficial femoral artery.A 6.0 x 100mm, 135cm ranger drug coated balloon was advanced.During the procedure, it was noted that the balloon twisted and it could not be resolved even after pressurizing up to 10 atmospheres.The procedure was completed with another of the same device.There were no patient complications as a result of this event.However, device analysis revealed balloon tear.
 
Event or Problem Description
Reportable based on device analysis completed on 05jan2026.It was reported balloon twisting occurred.The 75% stenosed target lesion was located in the moderately calcified superficial femoral artery.A 6.0 x 100mm, 135cm ranger drug coated balloon was advanced.During the procedure, it was noted that the balloon twisted and it could not be resolved even after pressurizing up to 10 atmospheres.The procedure was completed with another of the same device.There were no patient complications as a result of this event.However, device analysis revealed balloon tear.
 
Additional Manufacturer Narrative
Investigation results: device technical analysis upon receipt at our post market quality assurance laboratory, a visual examination identified that the balloon was not folded which indicates that the balloon was subjected to positive pressure.A longitudinal tear was identified in the balloon material.The tear measured approximately 24mm in length and extended from a position 21mm proximal of the distal markerband to 2mm distal of the distal markerband.The balloon material was visual examined and no twist was noted.The markerbands and tip section of the device were visually examined, and no issues were noted with the markerbands or tip of the device.A visual and tactile examination identified a shaft kink approximately 40mm proximal from the distal tip.No other issues were identified during the product analysis.Device history record (dhr) review.It was confirmed this device met manufacturing specifications prior to distribution and there were no manufacturing deviations that could have contributed to the reported event.Labeling review.Review of the instructions for use (ifu) confirmed that the content was sufficient and did not contribute to the reported event; therefore, no updates are required to the document at this time.Risk review.A review of the ranger (dcb) device confirmed that the reported event is a known event defined in the product's risk management documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER?
Common Device Name
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key24226617
Report Number2124215-2026-05641
Device Sequence Number15794449
Product Code ONU
UDI-Device Identifier08714729976141
UDI-Public(01)08714729976141(17)260118(10)431H24
Combination Product (Y/N)Y
Initial Reporter CountryJA
PMA/510(K) Number
P190019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative,Distributor
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/14/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/18/2026
Device Model NumberH74939419601010
Device Catalogue NumberH74939419601010
Device Lot Number00431H24
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/25/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/05/2026
Supplement Date Received by Manufacturer03/19/2026
Initial Report FDA Received Date01/30/2026
Supplement Report FDA Received Date04/14/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/19/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-